VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q59687413  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010848.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q59687413‏
024 ‎‡a  0000-0002-4571-7721‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q59687413‏
100 0 ‎‡a  David Jimenez‏ ‎‡c  researcher ORCID ID = 0000-0002-4571-7721‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  David Jimenez‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Accuracy and Interobserver Reliability of the Simplified Pulmonary Embolism Severity Index Versus the Hestia Criteria for Patients With Pulmonary Embolism‏
670 ‎‡a  Author's Assembly 13: placing the pulmonary circulation in the heart of ERS‏
670 ‎‡a  Author's Atrial fibrillation in the course of pulmonary embolism: just a little smoke, or fuel to the fire?‏
670 ‎‡a  Author's Clinical characteristics and 3-month outcomes in cancer patients with incidental <i>versus</i> clinically-suspected and confirmed pulmonary embolism‏
670 ‎‡a  Author's Comparative clinical prognosis of massive and non-massive pulmonary embolism: a registry-based cohort study‏
670 ‎‡a  Author's Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study.‏
670 ‎‡a  Author's Highlights from the ERS International Congress 2018: Assembly 13 - Pulmonary Vascular Diseases‏
670 ‎‡a  Author's Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study‏
670 ‎‡a  Author's Impact of obstructive sleep apnea on cardiovascular outcomes in patients with acute symptomatic pulmonary embolism: Rationale and methodology for the POPE study‏
670 ‎‡a  Author's Implications of Abnormal Troponin Levels With Normal Right Ventricular Function in Normotensive Patients With Acute Pulmonary Embolism‏
670 ‎‡a  Author's Management appropriateness and outcomes of patients with acute pulmonary embolism‏
670 ‎‡a  Author's Meta-Analysis of Prevalence and Short-Term Prognosis of Hemodynamically Unstable Patients With Symptomatic Acute Pulmonary Embolism‏
670 ‎‡a  Author's Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications‏
670 ‎‡a  Author's Outpatient therapy for acute symptomatic pulmonary embolism diagnosed in the emergency department: Time to improve the evidence base.‏
670 ‎‡a  Author's Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.‏
670 ‎‡a  Author's Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions‏
670 ‎‡a  Author's Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry‏
670 ‎‡a  Author's Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism‏
670 ‎‡a  Author's The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease‏
909 ‎‡a  (orcid) 0000000245717721‏ ‎‡9  1‏
919 ‎‡a  impactofobstructivesleepapneaoncardiovascularoutcomesinpatientswithacutesymptomaticpulmonaryembolismrationaleandmethodologyforthepopestudy‏ ‎‡A  Impact of obstructive sleep apnea on cardiovascular outcomes in patients with acute symptomatic pulmonary embolism: Rationale and methodology for the POPE study‏ ‎‡9  1‏
919 ‎‡a  sexdifferencesinthecharacteristicsandshorttermprognosisofpatientspresentingwithacutesymptomaticpulmonaryembolism‏ ‎‡A  Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism‏ ‎‡9  1‏
919 ‎‡a  implicationsofabnormaltroponinlevelswithnormalrightventricularfunctioninnormotensivepatientswithacutepulmonaryembolism‏ ‎‡A  Implications of Abnormal Troponin Levels With Normal Right Ventricular Function in Normotensive Patients With Acute Pulmonary Embolism‏ ‎‡9  1‏
919 ‎‡a  rateanddurationofhospitalisationforacutepulmonaryembolismintherealworldclinicalpracticeofdifferentcountriesanalysisfromtherieteregistry‏ ‎‡A  Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry‏ ‎‡9  1‏
919 ‎‡a  managementappropriatenessandoutcomesofpatientswithacutepulmonaryembolism‏ ‎‡A  Management appropriateness and outcomes of patients with acute pulmonary embolism‏ ‎‡9  1‏
919 ‎‡a  pulmonaryembolismresponseteamspurposeevidenceforefficacyandfutureresearchdirections‏ ‎‡A  Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions‏ ‎‡9  1‏
919 ‎‡a  prognosticimpactofcopeptininpulmonaryembolismamulticentrevalidationstudy‏ ‎‡A  Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.‏ ‎‡9  1‏
919 ‎‡a  outpatienttherapyforacutesymptomaticpulmonaryembolismdiagnosedintheemergencydepartmenttimetoimprovetheevidencebase‏ ‎‡A  Outpatient therapy for acute symptomatic pulmonary embolism diagnosed in the emergency department: Time to improve the evidence base.‏ ‎‡9  1‏
919 ‎‡a  metaanalysisofprevalenceandshorttermprognosisofhemodynamicallyunstablepatientswithsymptomaticacutepulmonaryembolism‏ ‎‡A  Meta-Analysis of Prevalence and Short-Term Prognosis of Hemodynamically Unstable Patients With Symptomatic Acute Pulmonary Embolism‏ ‎‡9  1‏
919 ‎‡a  obstructivesleepapnoeaandvenousthromboembolismpathophysiologicallinksandclinicalimplications‏ ‎‡A  Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications‏ ‎‡9  1‏
919 ‎‡a  accuracyandinterobserverreliabilityofthesimplifiedpulmonaryembolismseverityindexversusthehestiacriteriaforpatientswithpulmonaryembolism‏ ‎‡A  Accuracy and Interobserver Reliability of the Simplified Pulmonary Embolism Severity Index Versus the Hestia Criteria for Patients With Pulmonary Embolism‏ ‎‡9  1‏
919 ‎‡a  assembly13placingthepulmonarycirculationintheheartofers‏ ‎‡A  Assembly 13: placing the pulmonary circulation in the heart of ERS‏ ‎‡9  1‏
919 ‎‡a  atrialfibrillationinthecourseofpulmonaryembolismjustalittlesmokeorfueltothefire‏ ‎‡A  Atrial fibrillation in the course of pulmonary embolism: just a little smoke, or fuel to the fire?‏ ‎‡9  1‏
919 ‎‡a  clinicalcharacteristicsand3monthoutcomesincancerpatientswithincidental1versus1clinicallysuspectedandconfirmedpulmonaryembolism‏ ‎‡A  Clinical characteristics and 3-month outcomes in cancer patients with incidental <i>versus</i> clinically-suspected and confirmed pulmonary embolism‏ ‎‡9  1‏
919 ‎‡a  comparativeclinicalprognosisofmassiveandnonmassivepulmonaryembolismaregistrybasedcohortstudy‏ ‎‡A  Comparative clinical prognosis of massive and non-massive pulmonary embolism: a registry-based cohort study‏ ‎‡9  1‏
919 ‎‡a  diclofenacforreversalofrightventriculardysfunctioninacutenormotensivepulmonaryembolismapilotstudy‏ ‎‡A  Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study.‏ ‎‡9  1‏
919 ‎‡a  rationaledesignandmethodsofarandomizedcontrolledtrialtoevaluatetheefficacyandsafetyofanactivestrategyforthediagnosisandtreatmentofacutepulmonaryembolismduringexacerbationsofchronicobstructivepulmonarydisease‏ ‎‡A  The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease‏ ‎‡9  1‏
919 ‎‡a  highlightsfromtheersinternationalcongress2018assembly13pulmonaryvasculardiseases‏ ‎‡A  Highlights from the ERS International Congress 2018: Assembly 13 - Pulmonary Vascular Diseases‏ ‎‡9  1‏
919 ‎‡a  hospitalvolumeandoutcomesforacutepulmonaryembolismmultinationalpopulationbasedcohortstudy‏ ‎‡A  Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  ISNI|0000000026660593‏
996 ‎‡2  DNB|14021366X‏
996 ‎‡2  BNE|XX898583‏
996 ‎‡2  BNC|981058511977106706‏
996 ‎‡2  BNE|XX5554941‏
996 ‎‡2  SUDOC|236533649‏
996 ‎‡2  BNE|XX5380633‏
996 ‎‡2  SUDOC|112381707‏
996 ‎‡2  SUDOC|272936987‏
996 ‎‡2  W2Z|1707991623113‏
996 ‎‡2  ISNI|0000000059254305‏
996 ‎‡2  BNF|14470778‏
996 ‎‡2  BNF|16705304‏
996 ‎‡2  ISNI|0000000049548748‏
996 ‎‡2  BIBSYS|2095943‏
996 ‎‡2  LC|no2022095092‏
996 ‎‡2  ISNI|0000000119959762‏
996 ‎‡2  BNE|XX4992647‏
996 ‎‡2  ISNI|0000000433440619‏
996 ‎‡2  LC|no2015158693‏
996 ‎‡2  BNE|XX1223884‏
996 ‎‡2  ISNI|0000000048543590‏
996 ‎‡2  BNE|XX1542384‏
996 ‎‡2  ISNI|0000000118237522‏
996 ‎‡2  LC|no2021103192‏
996 ‎‡2  LC|no2011011666‏
996 ‎‡2  ISNI|0000000042926830‏
996 ‎‡2  BNE|XX4426640‏
996 ‎‡2  BNE|XX846281‏
996 ‎‡2  SUDOC|249907747‏
996 ‎‡2  ISNI|0000000078242625‏
996 ‎‡2  LC|n 86038873‏
996 ‎‡2  JPG|500291057‏
996 ‎‡2  BNC|981058517398906706‏
996 ‎‡2  LC|no2013135817‏
996 ‎‡2  ISNI|0000000116797462‏
996 ‎‡2  BIBSYS|90723985‏
996 ‎‡2  RERO|A009690246‏
996 ‎‡2  BNE|XX1538258‏
996 ‎‡2  ISNI|0000000024257397‏
996 ‎‡2  BNE|XX1416029‏
996 ‎‡2  SUDOC|259783579‏
996 ‎‡2  ISNI|0000000059307542‏
996 ‎‡2  BNF|17140971‏
996 ‎‡2  ISNI|0000000495887854‏
996 ‎‡2  ISNI|0000000131774795‏
996 ‎‡2  LC|ns2018000298‏
996 ‎‡2  LC|no2006053973‏
996 ‎‡2  SUDOC|262322943‏
996 ‎‡2  LC|no2010108963‏
996 ‎‡2  DNB|1140461249‏
996 ‎‡2  LC|ns2015001687‏
996 ‎‡2  BNE|XX4705019‏
996 ‎‡2  ISNI|0000000454459271‏
996 ‎‡2  DNB|1032971266‏
996 ‎‡2  BNF|16512733‏
996 ‎‡2  ISNI|0000000442462377‏
996 ‎‡2  BNC|981058510530006706‏
996 ‎‡2  BNE|XX5729948‏
996 ‎‡2  DNB|1151161942‏
996 ‎‡2  DNB|137584024‏
996 ‎‡2  SUDOC|060347449‏
996 ‎‡2  BNC|981058609184606706‏
996 ‎‡2  LC|no 93003482‏
996 ‎‡2  BNE|XX5578507‏
996 ‎‡2  BNE|XX843883‏
996 ‎‡2  BNC|981058479364806706‏
996 ‎‡2  BNE|XX1343375‏
996 ‎‡2  NTA|418046956‏
996 ‎‡2  BNE|XX1098084‏
996 ‎‡2  PLWABN|9810688020305606‏
996 ‎‡2  LC|no2020073414‏
996 ‎‡2  BNC|981058520273706706‏
996 ‎‡2  LC|n 2017005200‏
996 ‎‡2  LC|n 98000347‏
996 ‎‡2  ISNI|0000000063014558‏
996 ‎‡2  BNE|XX4662364‏
996 ‎‡2  PLWABN|9810556260005606‏
996 ‎‡2  ISNI|0000000043175012‏
996 ‎‡2  NTA|418973458‏
996 ‎‡2  LC|n 85175962‏
996 ‎‡2  LC|no 92028528‏
996 ‎‡2  ISNI|0000000088248449‏
996 ‎‡2  LC|no2019133388‏
996 ‎‡2  RERO|A006340424‏
996 ‎‡2  NDL|001358385‏
996 ‎‡2  ISNI|0000000039506093‏
996 ‎‡2  BNC|981058509161206706‏
996 ‎‡2  BNF|17168774‏
996 ‎‡2  DNB|1262346878‏
996 ‎‡2  BNC|981058610727206706‏
996 ‎‡2  BNE|XX5103983‏
996 ‎‡2  BNE|XX4665898‏
996 ‎‡2  SUDOC|195591623‏
996 ‎‡2  LC|n 2019024696‏
996 ‎‡2  NKC|xx0213581‏
996 ‎‡2  BNE|XX5556749‏
996 ‎‡2  BIBSYS|1707991623113‏
996 ‎‡2  BNE|XX6222650‏
996 ‎‡2  BNE|XX1706476‏
996 ‎‡2  BIBSYS|1675320984186‏
996 ‎‡2  NTA|417573464‏
996 ‎‡2  W2Z|1675320984186‏
996 ‎‡2  LC|no2009111050‏
996 ‎‡2  BNC|981058517229706706‏
996 ‎‡2  CAOONL|ncf13676454‏
996 ‎‡2  LC|no2022111168‏
996 ‎‡2  RERO|A003425806‏
996 ‎‡2  LC|no 99082993‏
996 ‎‡2  ISNI|0000000078734793‏
996 ‎‡2  LC|no2004084815‏
996 ‎‡2  LC|n 2008031156‏
996 ‎‡2  LC|ns2021000445‏
996 ‎‡2  LC|ns2023003209‏
996 ‎‡2  BNC|981058580316806706‏
996 ‎‡2  DNB|1057066729‏
996 ‎‡2  DNB|1116746506‏
996 ‎‡2  LC|no2007002426‏
996 ‎‡2  RERO|A024752547‏
996 ‎‡2  LC|n 93023034‏
996 ‎‡2  SUDOC|191591572‏
996 ‎‡2  LC|n 82275257‏
996 ‎‡2  J9U|987011416119105171‏
996 ‎‡2  BNE|XX5581016‏
996 ‎‡2  SUDOC|250715880‏
996 ‎‡2  BNC|981058508151906706‏
996 ‎‡2  SUDOC|149128991‏
996 ‎‡2  LC|no2006041287‏
996 ‎‡2  ISNI|0000000460598585‏
996 ‎‡2  NTA|148390196‏
996 ‎‡2  ISNI|0000000025399020‏
996 ‎‡2  LC|no2011044525‏
996 ‎‡2  SUDOC|179904949‏
996 ‎‡2  DNB|1154395723‏
996 ‎‡2  SUDOC|280965370‏
996 ‎‡2  SUDOC|26087471X‏
996 ‎‡2  BNE|XX4429127‏
996 ‎‡2  RERO|A027494208‏
996 ‎‡2  ISNI|0000000383177639‏
996 ‎‡2  BNC|981058609388506706‏
996 ‎‡2  LC|ns2018003206‏
996 ‎‡2  LC|n 2023008182‏
996 ‎‡2  BNF|16974969‏
996 ‎‡2  BNE|XX1141425‏
996 ‎‡2  BNF|17034222‏
996 ‎‡2  LIH|LNB:C_r_Q_y_;=CP‏
996 ‎‡2  NSK|000676087‏
996 ‎‡2  BNCHL|10000000000000000260533‏
996 ‎‡2  LC|n 2014047278‏
996 ‎‡2  LC|nr 99005547‏
996 ‎‡2  NTA|431870128‏
996 ‎‡2  ISNI|0000000038019314‏
996 ‎‡2  BNC|981058611801806706‏
996 ‎‡2  BNC|981060026162606706‏
996 ‎‡2  DNB|1074891872‏
996 ‎‡2  ISNI|0000000410242871‏
996 ‎‡2  SUDOC|132081210‏
996 ‎‡2  DNB|1057052256‏
996 ‎‡2  LC|n 80120421‏
996 ‎‡2  ISNI|000000006013479X‏
996 ‎‡2  ISNI|000000004489131X‏
996 ‎‡2  DNB|1252627092‏
996 ‎‡2  DNB|131806874‏
996 ‎‡2  BNE|XX1053649‏
996 ‎‡2  LC|no2021059836‏
996 ‎‡2  BNE|XX4994475‏
996 ‎‡2  BNC|981058512965406706‏
996 ‎‡2  PLWABN|9813658262005606‏
996 ‎‡2  PTBNP|1756667‏
996 ‎‡2  DNB|1057612995‏
996 ‎‡2  BNC|981058613182606706‏
996 ‎‡2  SUDOC|077328825‏
996 ‎‡2  LC|ns2022000677‏
996 ‎‡2  BNE|XX5266864‏
996 ‎‡2  BNF|17775404‏
996 ‎‡2  PLWABN|9811309963405606‏
996 ‎‡2  LC|no2009071750‏
996 ‎‡2  LC|no2016038495‏
996 ‎‡2  ISNI|0000000112188483‏
996 ‎‡2  LC|no2013072304‏
996 ‎‡2  LC|no2023119862‏
996 ‎‡2  BNE|XX4853810‏
996 ‎‡2  BNC|981058610343506706‏
996 ‎‡2  BNF|15053179‏
996 ‎‡2  LC|ns2011001793‏
996 ‎‡2  SUDOC|23461773X‏
996 ‎‡2  BNE|XX5051278‏
996 ‎‡2  SUDOC|176531327‏
996 ‎‡2  LC|n 2012061885‏
996 ‎‡2  DNB|1245892614‏
996 ‎‡2  PTBNP|1908194‏
996 ‎‡2  LC|nr2001017719‏
996 ‎‡2  NKC|jo2018991401‏
996 ‎‡2  BNC|981058517425106706‏
996 ‎‡2  JPG|500284598‏
996 ‎‡2  BNE|XX5595526‏
996 ‎‡2  NUKAT|nx2023000624‏
996 ‎‡2  ISNI|0000000039814811‏
996 ‎‡2  PTBNP|219785‏
996 ‎‡2  ISNI|0000000371894067‏
996 ‎‡2  DNB|116510069X‏
996 ‎‡2  BNCHL|10000000000000000099189‏
996 ‎‡2  ISNI|0000000420589430‏
996 ‎‡2  DNB|134774515‏
996 ‎‡2  PTBNP|569563‏
996 ‎‡2  BNC|981058520516106706‏
996 ‎‡2  BNE|XX5433424‏
996 ‎‡2  BNC|981058609963106706‏
996 ‎‡2  BNE|XX1537480‏
996 ‎‡2  BNE|XX1079093‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏